Literature DB >> 22632388

Probiotics and oral health.

Bernard Bizzini1, Giuseppe Pizzo, Giovanni Scapagnini, Domenico Nuzzo, Sonya Vasto.   

Abstract

Probiotics are living microorganisms (e.g., bacteria) that are either the same as or similar to organisms found naturally in the human body and may be beneficial to health. Current researches have shown that the balance between beneficial and pathogenic bacteria is essential in order to maintain the oral health. Therefore, oral cavity has recently been suggested as a relevant target for probiotic applications. Dental caries can be seen as a microbial imbalance where the oral microbiota shift towards community dominance which produces acidogenic and acid-tolerant gram positive bacteria. Similarly, the accumulation of bacteria within the biofilm, facilitated by poor oral hygiene, predisposes to allogenic shifts in the microbial community, leading to the onset of periodontal inflammation. Probiotic bacteria belonging to the genus of Lactobacillus, Bifidobacterium and Streptococcus have been proven effective for preventing caries by reducing the number of cariogenic bacteria in saliva after a short period of consuming the probiotic. In contrast, the effect of probiotics on improving gingivitis and periodontitis has been less investigated. The currently available studies on the effect of probiotics on periodontal pathogens and clinical periodontal parameters showed differing results depending on the strains used and the endpoints analyzed. Many of the clinical studies are pilot in nature and with low quality, therefore, properly conducted clinical trials, using probiotic strains with in vitro proven periodontal probiotic effects, are needed. The putative beneficial effects of probiotics on oral malodour have also been evaluated, but further evidence is needed to fully explore the potential of probiotics for preventing malodour.

Entities:  

Mesh:

Year:  2012        PMID: 22632388     DOI: 10.2174/138161212803307473

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  18 in total

1.  Recovery of Viable Bacteria from Probiotic Products that Target Oral Health.

Authors:  Jeffrey A Banas; Eric T Popp
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

2.  Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss.

Authors:  T Maekawa; G Hajishengallis
Journal:  J Periodontal Res       Date:  2014-02-01       Impact factor: 4.419

3.  Bacterial Populations in Subgingival Plaque Under Healthy and Diseased Conditions: Genomic Insights into Oral Adaptation Strategies by Lactobacillus sp. Strain DISK7.

Authors:  Deepika Sharma; Shikha Sharma; Vijay Pal; Rup Lal; Prabhu Patil; Vishakha Grover; Suresh Korpole
Journal:  Indian J Microbiol       Date:  2019-10-08       Impact factor: 2.461

Review 4.  The Role of Oral Pathobionts in Dysbiosis during Periodontitis Development.

Authors:  Y Jiao; M Hasegawa; N Inohara
Journal:  J Dent Res       Date:  2014-03-19       Impact factor: 6.116

5.  Consequences of orthodontic treatment in malocclusion patients: clinical and microbial effects in adults and children.

Authors:  Li Guo; Ying Feng; Hong-Gang Guo; Bo-Wen Liu; Yang Zhang
Journal:  BMC Oral Health       Date:  2016-10-28       Impact factor: 2.757

Review 6.  Probiotics to counteract biofilm-associated infections: promising and conflicting data.

Authors:  Claudia Vuotto; Francesca Longo; Gianfranco Donelli
Journal:  Int J Oral Sci       Date:  2014-09-26       Impact factor: 6.344

Review 7.  The ecological community of commensal, symbiotic, and pathogenic gastrointestinal microorganisms - an appraisal.

Authors:  Seraj Zohurul Haque; Mainul Haque
Journal:  Clin Exp Gastroenterol       Date:  2017-05-05

Review 8.  Probiotics: A Promising Role in Dental Health.

Authors:  Sari A Mahasneh; Adel M Mahasneh
Journal:  Dent J (Basel)       Date:  2017-09-27

9.  Lactobacillus rhamnosus could inhibit Porphyromonas gingivalis derived CXCL8 attenuation.

Authors:  Ayşegül Mendi; Sevil Köse; Duygu Uçkan; Gülçin Akca; Derviş Yilmaz; Levent Aral; Sibel Elif Gültekin; Tamer Eroğlu; Emine Kiliç; Sina Uçkan
Journal:  J Appl Oral Sci       Date:  2016 Jan-Feb       Impact factor: 2.698

10.  D‑Tagatose inhibits the growth and biofilm formation of Streptococcus mutans.

Authors:  Khaleque Hasibul; Haruyuki Nakayama-Imaohji; Masahito Hashimoto; Hisashi Yamasaki; Takaaki Ogawa; Junpei Waki; Ayano Tada; Saori Yoneda; Masaaki Tokuda; Minoru Miyake; Tomomi Kuwahara
Journal:  Mol Med Rep       Date:  2017-11-08       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.